HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ralf Buettner Selected Research

Ralf Buettner Research Topics

Disease

22Neoplasms (Cancer)
01/2022 - 04/2002
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2024 - 03/2016
5Carcinogenesis
01/2022 - 04/2002
5Prostatic Neoplasms (Prostate Cancer)
02/2014 - 11/2002
3Multiple Myeloma
12/2020 - 01/2018
3Ovarian Neoplasms (Ovarian Cancer)
08/2019 - 12/2014
3Melanoma (Melanoma, Malignant)
11/2013 - 11/2008
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 09/2019
2Rheumatoid Arthritis
01/2020 - 09/2019
2Neuroblastoma
07/2013 - 05/2012
2Medulloblastoma
04/2012 - 11/2008
2Breast Neoplasms (Breast Cancer)
05/2008 - 10/2005
1Ascites
12/2014
1Glioblastoma (Glioblastoma Multiforme)
04/2010
1Glioma (Gliomas)
04/2010
1Hematologic Neoplasms (Hematological Malignancy)
11/2008
1Neoplasm Metastasis (Metastasis)
08/2007
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2005
1Adenocarcinoma
11/2002

Drug/Important Bio-Agent (IBA)

7Phosphotransferases (Kinase)IBA
09/2019 - 04/2002
6Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2002
4STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
03/2016 - 04/2005
4Interleukin-6 (Interleukin 6)IBA
12/2014 - 05/2012
4src-Family KinasesIBA
11/2012 - 10/2005
3venetoclaxIBA
04/2024 - 01/2021
3Transcription Factors (Transcription Factor)IBA
03/2016 - 05/2011
3CytokinesIBA
12/2014 - 04/2002
3Small Interfering RNA (siRNA)IBA
12/2014 - 12/2009
3Sorafenib (BAY 43-9006)FDA Link
05/2012 - 11/2008
2GemcitabineFDA Link
01/2021 - 09/2019
2Leflunomide (Arava)FDA LinkGeneric
01/2020 - 09/2019
2Janus Kinase InhibitorsIBA
08/2019 - 11/2013
2Janus KinasesIBA
11/2014 - 04/2002
2Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
02/2014 - 07/2013
2Apoptosis Regulatory ProteinsIBA
04/2012 - 11/2008
2Dasatinib (BMS 354825)FDA Link
11/2008 - 10/2005
1Methionine (L-Methionine)FDA Link
01/2022
15'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA
01/2022
1TransferasesIBA
01/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1pyrimidineIBA
01/2021
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
12/2020
1Immunosuppressive Agents (Immunosuppressants)IBA
09/2019
1Tyrosine Kinase InhibitorsIBA
09/2019
1NucleosidesIBA
09/2019
1daratumumabIBA
01/2018
1CopperIBA
01/2018
1Immunoglobulin E (IgE)IBA
02/2016
1Gefitinib (Iressa)FDA Link
05/2015
1Janus Kinase 1IBA
12/2014
1Biomarkers (Surrogate Marker)IBA
12/2014
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
11/2014
1Toll-Like Receptors (Toll-Like Receptor)IBA
11/2014
1MicroRNAs (MicroRNA)IBA
11/2014
1Androgen Receptors (Androgen Receptor)IBA
02/2014
1InterleukinsIBA
07/2013
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
05/2012
1Cyclin D1IBA
05/2012
1SurvivinIBA
05/2012
1Cyclin EIBA
05/2012
1Bortezomib (Velcade)FDA Link
04/2012
1benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA
04/2012
1CaspasesIBA
04/2012
1Proteasome InhibitorsIBA
04/2012
1Annexin A5IBA
01/2012
1spirooxindoleIBA
01/2012
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2012
1AZD 1480IBA
12/2009
1Cytokine Receptors (Cytokine Receptor)IBA
12/2009
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
11/2008
1Mitogen-Activated Protein Kinase 3IBA
11/2008
1Mitogen-Activated Protein KinasesIBA
11/2008
1EphA2 ReceptorIBA
11/2008
1bosutinibIBA
05/2008
1Complement System Proteins (Complement)IBA
08/2007
1Focal Adhesion Protein-Tyrosine KinasesIBA
10/2005
1InterferonsIBA
05/2005
1indirubinIBA
04/2005
1EnzymesIBA
04/2002
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2002
1LigandsIBA
04/2002
1ErbB Receptors (EGF Receptor)IBA
04/2002
1CyclinsIBA
04/2002
1Tyrosine (L-Tyrosine)FDA Link
04/2002

Therapy/Procedure

4Therapeutics
01/2022 - 11/2002
2Drug Therapy (Chemotherapy)
09/2019 - 01/2012
1Prostatectomy (Retropubic Prostatectomy)
11/2002